Sinclair Andrew
- SEC CIK
- 0001762451
Latest role at each company
- ACET Adicet Bio, Inc.Directoras of Jun 23, 2026
- CIK 0001484565Directoras of May 18, 2026
- CIK 0001290149Directoras of Jul 1, 2022
- CIK 0001657312Directoras of Aug 10, 2021
Trades
Every Form 4 that lists Sinclair Andrew as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| – | Mar 31, 2022 | Mar 29, 2022 | Sinclair AndrewDirector | PPurchaseCommon Stock | +7.72M | – | – | 18.02M | +74.9% | SEC |
| – | Mar 31, 2022 | Mar 29, 2022 | Sinclair AndrewDirector | PPurchaseCommon Stock · Derivative | +7.72M | – | – | 7.72M | – | SEC |
| – | Feb 1, 2022 | Jan 31, 2022 | Sinclair AndrewDirector | PPurchaseCommon Stock, $0.001 par value | +150K | $27.00 | +$4.05M | 1.31M | +12.9% | SEC |
| ACETAdicet Bio, Inc. | Dec 13, 2021Amended | Dec 8, 2021 | Sinclair AndrewDirector | PPurchaseCommon Stock | +500K | $14.00 | +$7M | 2.12M | +31.0% | SEC |